Home announces
 

Keywords :   


Tag: announces

Olympic Paints Announces Partnership with This Old House 2016 Idea House

2016-10-10 21:00:00| Coatings World Breaking News

Tags: house idea partnership announces

 

ITF announces petrophysics JIP

2016-10-09 20:00:00| Oil IT Journal - www.oilit.com

Petgas III to further develop PETMiner software.

Tags: announces itf jip petrophysics

 
 

Merck Announces Longer-Term Follow-Up of Overall Survival Data for KEYTRUDA (pembrolizumab) in Patients with Advanced Melanoma from KEYNOTE-002 Presented at ESMO 2016 Congress

2016-10-08 14:45:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. Data Comparing KEYTRUDA to Chemotherapy Shows Continued Benefit with Follow-Up Beyond 2.5 Years in Patients with Ipilimumab-Refractory Advanced Melanoma KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced findings from the final overall survival (OS) analysis from the KEYNOTE-002 study investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, compared to investigator-choice chemotherapy with a crossover to KEYTRUDA design, in patients with ipilimumab-refractory advanced melanoma. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orKim Hamilton, 908-740-1863orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: data advanced presented patients

 

Merck Animal Health Announces USDA Approval of Innovative Canine Flu Bivalent Vaccine

2016-10-07 22:05:00| Merck.com - Corporate News

Dateline City: MADISON, N.J. First Vaccine to Offer Protection Against Both Strains of Canine Influenza MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today announced that the U.S. Department of Agriculture has approved a license for Nobivac Canine Flu Bivalent vaccine the first vaccine to aid in the control of disease associated with both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8. Language: English Contact: MerckMedia:Kelly Goss, 913-558-6452 kelly.goss@merck.com orPamela Eisele, 267-305-3558 pamela.eisele@merck.com orInvestor Relations:Amy Klug, 908-740-1898 amy.klug@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: health animal approval innovative

 

Flint Group announces winners of 12th Annual Narrow Web Print Awards

2016-10-07 16:00:00| Label and Narrow Web Breaking News

Tags: web group print annual

 

Sites : [416] [417] [418] [419] [420] [421] [422] [423] [424] [425] [426] [427] [428] [429] [430] [431] [432] [433] [434] [435] next »